Literature DB >> 29751044

Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c.

Abisola Abisoye-Ogunniyan1, Huxian Lin1, Anghesom Ghebremedhin1, Ahmad Bin Salam1, Balasubramanyam Karanam1, Shaniece Theodore1, Jacqueline Jones-Trich2, Melissa Davis3, William Grizzle4, Honghe Wang1, Clayton Yates5.   

Abstract

The loss of miR-200 family, through DNA methylation, results in cancer cells undergoing an epithelial to mesenchymal transition (EMT), and metastasis. In this study, we established that the transcriptional repressor Kaiso directly binds methylated regions of the miR-200 family, and this is reversed with 5-aza treatment. sh-Kaiso PC-3 cells display increased miR-200-a/b/c, miR-141, and miR-429 expression, with miR-200c demonstrating the most significant increase. Interestingly, overexpression of EGFR or treatment with EGF decreases miR-200c expression and this is reversed after treatment with EGFR specific kinase inhibitor PD153035. However, EGF did not have a significant effect on miR-200c in sh-Kaiso DU-145 or PC-3 cell lines, suggesting Kaiso silences miR-200c through the activation of EGFR signaling. Overexpression of Kaiso in LNCaP cells results in decreased expression of miR-200-a/b/c, miR-141, and miR-429, along with increased expression of ZEB1, p-EGFR and total EGFR levels. Overexpression of miR200c in PC-3 cells results in decreased expression of EGFR, ZEB1, ERK1/2 and Kaiso. Additionally, sh-Kaiso PC-3 demonstrates reduced in vivo tumor formation and metastasis. Thus, our data suggests that EGFR signaling regulates the silencing of miR-200 family through Kaiso binding to methylated regions in the promoter.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA methylation; Epithelial to mesenchymal transition; Kaiso; Metastasis; Prostate cancer

Mesh:

Substances:

Year:  2018        PMID: 29751044      PMCID: PMC6158022          DOI: 10.1016/j.canlet.2018.04.044

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   9.756


  33 in total

Review 1.  Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment.

Authors:  Joyce C Tse; Raghu Kalluri
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

2.  miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.

Authors:  R Perdigão-Henriques; F Petrocca; G Altschuler; M P Thomas; M T N Le; S M Tan; W Hide; J Lieberman
Journal:  Oncogene       Date:  2015-03-23       Impact factor: 9.867

3.  A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.

Authors:  Cameron P Bracken; Philip A Gregory; Natasha Kolesnikoff; Andrew G Bert; Jun Wang; M Frances Shannon; Gregory J Goodall
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 4.  Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?

Authors:  Maximilian Bockhorn; Rakesh K Jain; Lance L Munn
Journal:  Lancet Oncol       Date:  2007-05       Impact factor: 41.316

5.  In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals.

Authors:  H Xie; T Turner; M H Wang; R K Singh; G P Siegal; A Wells
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

6.  miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.

Authors:  Dejuan Kong; Yiwei Li; Zhiwei Wang; Sanjeev Banerjee; Aamir Ahmad; Hyeong-Reh Choi Kim; Fazlul H Sarkar
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

7.  Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer.

Authors:  Jeroen F Vermeulen; Robert A H van de Ven; Cigdem Ercan; Petra van der Groep; Elsken van der Wall; Peter Bult; Matthias Christgen; Ulrich Lehmann; Juliet Daniel; Paul J van Diest; Patrick W B Derksen
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

Review 8.  The epithelial-mesenchymal transition: new insights in signaling, development, and disease.

Authors:  Jonathan M Lee; Shoukat Dedhar; Raghu Kalluri; Erik W Thompson
Journal:  J Cell Biol       Date:  2006-03-27       Impact factor: 10.539

9.  miR-200b inhibits prostate cancer EMT, growth and metastasis.

Authors:  LaTanya V Williams; Dorina Veliceasa; Elena Vinokour; Olga V Volpert
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

10.  Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells.

Authors:  Lukas Vrba; Taylor J Jensen; James C Garbe; Ronald L Heimark; Anne E Cress; Sally Dickinson; Martha R Stampfer; Bernard W Futscher
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more
  9 in total

1.  Diversity in the Era of Precision Medicine - From Bench to Bedside Implementation.

Authors:  Abdullah Mamun; Nana Y Nsiah; Meenakshi Srinivasan; Ayyappa Chaturvedula; Riyaz Basha; Deanna Cross; Harlan P Jones; Karabi Nandy; Jamboor K Vishwanatha
Journal:  Ethn Dis       Date:  2019-07-18       Impact factor: 1.847

Review 2.  Dancing from bottoms up - Roles of the POZ-ZF transcription factor Kaiso in Cancer.

Authors:  Christina C Pierre; Shawn M Hercules; Clayton Yates; Juliet M Daniel
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-11-09       Impact factor: 11.414

3.  A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma.

Authors:  Erbao Bian; Xueran Chen; Yadi Xu; Xinghu Ji; Meng Cheng; Hongliang Wang; Zhiyou Fang; Bing Zhao
Journal:  J Exp Clin Cancer Res       Date:  2019-08-20

4.  Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer.

Authors:  Maud de Dieuleveult; Claire Marchal; Anne Jouinot; Anne Letessier; Benoit Miotto
Journal:  Cancers (Basel)       Date:  2020-04-29       Impact factor: 6.639

5.  Relationship between High Expression of Kaiso Protein and Poor Prognosis of Lung Cancer and the Regulation Mechanism of Malignant Phenotype of Lung Cancer Cells.

Authors:  Shasha Zhu; Ning Zhou; Ning Ding; Shanshan Li; Xiaoxing Liu; Guangming Ren; Qingling Li; Min Zhou
Journal:  J Oncol       Date:  2021-12-22       Impact factor: 4.375

6.  What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1.

Authors:  Andrea Palicelli; Stefania Croci; Alessandra Bisagni; Eleonora Zanetti; Dario De Biase; Beatrice Melli; Francesca Sanguedolce; Moira Ragazzi; Magda Zanelli; Alcides Chaux; Sofia Cañete-Portillo; Maria Paola Bonasoni; Alessandra Soriano; Stefano Ascani; Maurizio Zizzo; Carolina Castro Ruiz; Antonio De Leo; Guido Giordano; Matteo Landriscina; Giuseppe Carrieri; Luigi Cormio; Daniel M Berney; Jatin Gandhi; Davide Nicoli; Enrico Farnetti; Giacomo Santandrea; Martina Bonacini
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

Review 7.  The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.

Authors:  Ilaria Cavallari; Francesco Ciccarese; Evgeniya Sharova; Loredana Urso; Vittoria Raimondi; Micol Silic-Benussi; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

Review 8.  Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy.

Authors:  Mohammad Reza Karimzadeh; Peyman Pourdavoud; Naeim Ehtesham; Mohaddese Qadbeigi; Masood Movahedi Asl; Behrang Alani; Meysam Mosallaei; Bahram Pakzad
Journal:  Cancer Gene Ther       Date:  2020-08-10       Impact factor: 5.987

Review 9.  Epithelial-Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics.

Authors:  Luiz Paulo Chaves; Camila Morais Melo; Fabiano Pinto Saggioro; Rodolfo Borges Dos Reis; Jeremy Andrew Squire
Journal:  Genes (Basel)       Date:  2021-11-27       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.